Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning

Marco Armando, Ashleigh Lin, Maria Pontillo, Stefano Vicari

Research output: Contribution to journalArticle

1 Citation (Scopus)
69 Downloads (Pure)

Abstract

Individuals with chromosome 22q11 deletion syndrome (22q11DS) have high rates of psychotic disorders. Less is known about their psychopathology and how it is treated prior to the peak period of risk for psychotic disorder. There is also a lack of evidence on how functioning is impacted by psychopathology in this population. The aim of this study was to investigate the prevalence and treatment of non-psychotic psychiatric disorders, and how these factors are associated with psychosocial functioning in children and adolescents with 22q11DS. 126 individuals with 22q11DS aged 8–17 participated in the study. Participants were assessed for psychiatric diagnoses, social and role functioning, anxiety and depressive symptoms and IQ. Information on current treatments was collected. 52.4% of the sample presented with at least one psychiatric disorder. Mood and anxiety disorders were the most frequent, followed by behavioural disorder. Individuals with a psychiatric disorder had significantly lower general, role and social functioning. Only 27% of participants with a psychiatric diagnosis were receiving any mental health treatment at the time of assessment. Findings suggest the high prevalence of psychiatric disorders in youth with 22q11DS, which significantly impacts psychosocial functioning. Despite this, psychiatric disorders tend to remain untreated in this population.

Original languageEnglish
Pages (from-to)238-243
Number of pages6
JournalPsychiatry Research
Volume254
DOIs
Publication statusPublished - 1 Aug 2017

Fingerprint

22q11 Deletion Syndrome
Psychotic Disorders
Psychiatry
Psychopathology
Mental Disorders
Therapeutics
Chromosome Deletion
Anxiety Disorders
Mood Disorders
Population
Mental Health
Anxiety
Depression

Cite this

@article{c2e3a6950caa47a586d21e0958807952,
title = "Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning",
abstract = "Individuals with chromosome 22q11 deletion syndrome (22q11DS) have high rates of psychotic disorders. Less is known about their psychopathology and how it is treated prior to the peak period of risk for psychotic disorder. There is also a lack of evidence on how functioning is impacted by psychopathology in this population. The aim of this study was to investigate the prevalence and treatment of non-psychotic psychiatric disorders, and how these factors are associated with psychosocial functioning in children and adolescents with 22q11DS. 126 individuals with 22q11DS aged 8–17 participated in the study. Participants were assessed for psychiatric diagnoses, social and role functioning, anxiety and depressive symptoms and IQ. Information on current treatments was collected. 52.4{\%} of the sample presented with at least one psychiatric disorder. Mood and anxiety disorders were the most frequent, followed by behavioural disorder. Individuals with a psychiatric disorder had significantly lower general, role and social functioning. Only 27{\%} of participants with a psychiatric diagnosis were receiving any mental health treatment at the time of assessment. Findings suggest the high prevalence of psychiatric disorders in youth with 22q11DS, which significantly impacts psychosocial functioning. Despite this, psychiatric disorders tend to remain untreated in this population.",
keywords = "22q11.2 deletion syndrome (22q11DS), DiGeorge syndrome, Functioning, Psychiatric diagnosis, Psychosocial, Treatment, Velocardiofacial syndrome",
author = "Marco Armando and Ashleigh Lin and Maria Pontillo and Stefano Vicari",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.psychres.2017.04.019",
language = "English",
volume = "254",
pages = "238--243",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier",

}

Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS : Examining associations with social and role functioning. / Armando, Marco; Lin, Ashleigh; Pontillo, Maria; Vicari, Stefano.

In: Psychiatry Research, Vol. 254, 01.08.2017, p. 238-243.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS

T2 - Examining associations with social and role functioning

AU - Armando, Marco

AU - Lin, Ashleigh

AU - Pontillo, Maria

AU - Vicari, Stefano

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Individuals with chromosome 22q11 deletion syndrome (22q11DS) have high rates of psychotic disorders. Less is known about their psychopathology and how it is treated prior to the peak period of risk for psychotic disorder. There is also a lack of evidence on how functioning is impacted by psychopathology in this population. The aim of this study was to investigate the prevalence and treatment of non-psychotic psychiatric disorders, and how these factors are associated with psychosocial functioning in children and adolescents with 22q11DS. 126 individuals with 22q11DS aged 8–17 participated in the study. Participants were assessed for psychiatric diagnoses, social and role functioning, anxiety and depressive symptoms and IQ. Information on current treatments was collected. 52.4% of the sample presented with at least one psychiatric disorder. Mood and anxiety disorders were the most frequent, followed by behavioural disorder. Individuals with a psychiatric disorder had significantly lower general, role and social functioning. Only 27% of participants with a psychiatric diagnosis were receiving any mental health treatment at the time of assessment. Findings suggest the high prevalence of psychiatric disorders in youth with 22q11DS, which significantly impacts psychosocial functioning. Despite this, psychiatric disorders tend to remain untreated in this population.

AB - Individuals with chromosome 22q11 deletion syndrome (22q11DS) have high rates of psychotic disorders. Less is known about their psychopathology and how it is treated prior to the peak period of risk for psychotic disorder. There is also a lack of evidence on how functioning is impacted by psychopathology in this population. The aim of this study was to investigate the prevalence and treatment of non-psychotic psychiatric disorders, and how these factors are associated with psychosocial functioning in children and adolescents with 22q11DS. 126 individuals with 22q11DS aged 8–17 participated in the study. Participants were assessed for psychiatric diagnoses, social and role functioning, anxiety and depressive symptoms and IQ. Information on current treatments was collected. 52.4% of the sample presented with at least one psychiatric disorder. Mood and anxiety disorders were the most frequent, followed by behavioural disorder. Individuals with a psychiatric disorder had significantly lower general, role and social functioning. Only 27% of participants with a psychiatric diagnosis were receiving any mental health treatment at the time of assessment. Findings suggest the high prevalence of psychiatric disorders in youth with 22q11DS, which significantly impacts psychosocial functioning. Despite this, psychiatric disorders tend to remain untreated in this population.

KW - 22q11.2 deletion syndrome (22q11DS)

KW - DiGeorge syndrome

KW - Functioning

KW - Psychiatric diagnosis

KW - Psychosocial

KW - Treatment

KW - Velocardiofacial syndrome

UR - http://www.scopus.com/inward/record.url?scp=85018951650&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2017.04.019

DO - 10.1016/j.psychres.2017.04.019

M3 - Article

VL - 254

SP - 238

EP - 243

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

ER -